Marksans Pharma informs about statement of investor complaints

10 Jan 2018 Evaluate

Marksans Pharma has informed about Statement of Investor Complaints for the quarter ended December, 2017 under Regulation 13(3) of SEBI (LODR), 2015.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

161.05 -2.05 (-1.26%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×